Skip to main content

Advertisement

Table 3 Clinical characteristics and echocardiographic measurements of three sub-groups

From: Investigation on left ventricular multi-directional deformation in patients of hypertension with different LVEF

  group A group B group C
n = 71 n = 13 n = 34
Age(y) 57.99 ± 11.94 56.31 ± 14.07 57.62 ± 14.42
Gender(M/F) 53/18 11/2 28/6
HR(beats/min) 69.54 ± 11.97 66.92 ± 9.67 80.50 ± 15.81
LVIDd(cm) 5.17 ± 0.56 5.61 ± 0.47 6.10 ± 0.88
RWT 0.44 ± 0.10 0.41 ± 0.11 0.38 ± 0.12
LVEDVI(ml/ m2) 74.61 ± 15.56 91.14 ± 19.56 114.97 ± 41.34
LVMI(g/ m2) 132.09 ± 44.70 151.45 ± 42.37 181.44 ± 51.20
LAD(cm) 3.99 ± 0.56 4.11 ± 0.66 4.45 ± 0.64
LAVI(ml/m2) 31.33 ± 9.19 31.91 ± 9.76 42.69 ± 17.71
LVEF(%) 62.65 ± 4.14 49.45 ± 2.51 34.79 ± 7.24
s(m/s) 0.07 ± 0.03 0.06 ± 0.02 0.05 ± 0.02
E/e 11.13 ± 4.17 11.19 ± 3.79 18.76 ± 11.78
e(m/s) 0.07 ± 0.06 0.06 ± 0.03 0.05 ± 0.02
  1. Data are expressed as mean ± standard deviation (SD) or as number (ratio); HR heart rate, LVIDd Left ventricular internal dimension in diastole, RWT Relative wall thickness, LVEDVI Left ventricular end-diastolic volume index, LVMI Left ventricular mass index, LAD Left atrial diameter, LAVI LA volume index, LVEF Left ventricular ejection fraction; the data of normal controls (NC) see Table one; group A, normal LVEF and LV end diastolic volume index, group B, “borderline” LVEF and enlarged LV end diastolic volume index, group C, reduced LVEF (LVEF < 45%). p < 0.05 vs NC; p < 0.05 vs group A; p < 0.05 group B